Therapeutic strategies for infections due to Pseudomonas aeruginosa;Stratégies thérapeutiques dans les infections à Pseudomonas aeruginosa

Annales Francaises d'Anesthesie et de Reanimation

Volumn 22, Issue 6, 2003, Pages 534-538

  Bedos, J P ^a  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

Author keywords

Antibiotic resistance; Antibiotic sensitivity; Probabilistic antibiotherapy; Pseudomonas aeruginosa

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; IMIPENEM; NEOMYCIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIOLOGY; FRANCE; GRAM NEGATIVE INFECTION; HUMAN; PROBABILITY; PSEUDOMONAS AERUGINOSA;

EID: 0041975975     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(03)00167-9     Document Type: Article

References (10)

1. Harris AD, Smith D, Johnson JA, Bradham DD, Roghmann MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 2002;34:340-5.
2. El Amari EB, Chamot E, Auckenthaler R, Pechere JC, Van Delden C. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin Infect Dis 2001;33:1859-64.
3. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 1999;43:1379-82.
4. Harris AD, Perencevich R, Roghmann MC, Morris G, Kaye KS, Johnson JA. Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients. Antimicrob Agents Chemother 2002;46:854-8.
5. Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gibert C. Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant vs piperacillin-susceptible organisms. Clin Infect Dis 2002;34:1047-54.
6. Martinez-Rodriguez JE, Barriga FJ, Santamaria J, Iranzo A, Pareja JA, Revilla M, et al. Nonconvulsive status epilepticus associated with cephalosporins in patients with renal failure. Am J Med 2001;111:115-9.
7. Mokhtari M, Trouillet JL, Combes A, Baudot J, Chastre J, Gibert C. Traitement par aérosols de colimycine des pneumonies acquises sous ventilation mécanique dues à des souches de Pseudomonas aeruginosa ou Acinetobacter baumannii multirésistants. SRLF. Congrès de la Société de réanimation de langue française. janvier 2002. p. 16-8 abstract SP258.
8. Goldstein I, Wallet F, Nicolas-Robin A, Ferrari F, Marquette CH, Rouby JJ. Lung deposition and efficiency of nebulized amikacin during Escherichia coli pneumonia in ventilated piglets. Am J Respir Crit Care Med 2002;166:1375-81.
9. Levin AS, Barone AA, Penco J, Santos MC, Marinho IS, Arruda EA, et al. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 1999;28:1008-11.
10. Dennesen PJW, van der Ven AJAM, Kessels AGH, Ramsay G, Bonten MJM. Resolufion of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia. Am J Respir Crit Care Med 2001;163:1371-5.